Austar Lifesciences (06118) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express03-16

Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes:

• Approval of the consolidated results for the financial year ended 31 December 2025.

• Consideration of a final dividend recommendation, if any, for the same period.

The notice, dated 16 March 2026, confirms that the board currently comprises four executive directors (Ho Kwok Keung, Ho Kin Hung, Zhou Ning and Bian Ce), one non-executive director (Ji Lingling) and three independent non-executive directors (Cheung Lap Kei, Chiu Hoi Shan and Leung Oi Kin).

The meeting outcome will determine the publication of the company’s audited FY 2025 financial statements and any proposed dividend distribution to shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190363908?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 17:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190363908","market":"hk","top_or_hot":-1,"title":"Austar Lifesciences (06118) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal","media":"Bulletin Express","content":"<p>Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes:</p>\n<p>• Approval of the consolidated results for the financial year ended 31 December 2025.</p>\n<p>• Consideration of a final dividend recommendation, if any, for the same period.</p>\n<p>The notice, dated 16 March 2026, confirms that the board currently comprises four executive directors (Ho Kwok Keung, Ho Kin Hung, Zhou Ning and Bian Ce), one non-executive director (Ji Lingling) and three independent non-executive directors (Cheung Lap Kei, Chiu Hoi Shan and Leung Oi Kin).</p>\n<p>The meeting outcome will determine the publication of the company’s audited FY 2025 financial statements and any proposed dividend distribution to shareholders.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Austar Lifesciences (06118) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAustar Lifesciences (06118) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 17:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes:</p>\n<p>• Approval of the consolidated results for the financial year ended 31 December 2025.</p>\n<p>• Consideration of a final dividend recommendation, if any, for the same period.</p>\n<p>The notice, dated 16 March 2026, confirms that the board currently comprises four executive directors (Ho Kwok Keung, Ho Kin Hung, Zhou Ning and Bian Ce), one non-executive director (Ji Lingling) and three independent non-executive directors (Cheung Lap Kei, Chiu Hoi Shan and Leung Oi Kin).</p>\n<p>The meeting outcome will determine the publication of the company’s audited FY 2025 financial statements and any proposed dividend distribution to shareholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06118","symbol_name":"奥星生命科技","start_time":0,"source_url":"","article_id":"1190363908","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190363908","pubTimestamp":1773654059,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes: • Approval of the consolidated results for the financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06118":"奥星生命科技"},"translate_title":"奥星生命科技(06118)定于2026年3月26日召开董事会批准2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06118":1},"content_text":"Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes:\n• Approval of the consolidated results for the financial year ended 31 December 2025.\n• Consideration of a final dividend recommendation, if any, for the same period.\nThe notice, dated 16 March 2026, confirms that the board currently comprises four executive directors (Ho Kwok Keung, Ho Kin Hung, Zhou Ning and Bian Ce), one non-executive director (Ji Lingling) and three independent non-executive directors (Cheung Lap Kei, Chiu Hoi Shan and Leung Oi Kin).\nThe meeting outcome will determine the publication of the company’s audited FY 2025 financial statements and any proposed dividend distribution to shareholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190363908","isCrawlerRequest":true}